ClinConnect ClinConnect Logo
Search / Trial NCT06699030

A Strategy for Gallstone Expulsion Through Dietary Therapy

Launched by HEPATOPANCREATOBILIARY SURGERY INSTITUTE OF GANSU PROVINCE · Nov 19, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Gallstone Gallbladder Function Cholecystitis Ultrasound Examination

ClinConnect Summary

This clinical trial is investigating whether a special diet can help people get rid of small gallstones in the gallbladder. The study is taking place at a hospital and is looking for participants who are between the ages of 65 and 75 and have gallbladder stones that are less than 2 millimeters in size. Some people may not be eligible if they have had certain medical procedures, surgeries, or specific health conditions affecting the gallbladder or other parts of the digestive system.

If you qualify to join the study, you will follow a dietary plan that researchers believe may help in expelling these stones. The trial is currently recruiting participants, and everyone involved will not know whether they are receiving the actual dietary therapy or a placebo (a non-active treatment) to ensure fair results. This study aims to see if dietary changes can be a safe and effective way to manage gallstones without surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Gallbladder sludge-like stones with a maximum stone diameter of less than 2 mm
  • Exclusion Criteria:
  • History of ERCP (Endoscopic Retrograde Cholangiopancreatography)
  • Previous gallstone removal surgery with gallbladder preservation
  • History of acute or chronic pancreatitis, cholangitis
  • Mirizzi Syndrome
  • History of gastrointestinal surgery
  • Gastrointestinal obstruction
  • Dysfunction of the sphincter of Oddi
  • Gallbladder neck polyps
  • Abnormal gallbladder structure
  • Gallbladder mass
  • Biliary infection or stones
  • Congenital biliary abnormalities
  • Biliary injury or surgery
  • Biliary tumors
  • Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases
  • Significant arrhythmia, bradycardia, or atrioventricular block
  • Severe hypertension, liver or kidney insufficiency
  • Immune, endocrine, hematological, or mental disorders
  • Severe cerebrovascular disease
  • Allergy to relevant foods
  • Pregnant or breastfeeding women
  • Unwillingness or inability to consent to participation

About Hepatopancreatobiliary Surgery Institute Of Gansu Province

The Hepatopancreatobiliary Surgery Institute of Gansu Province is a leading clinical research organization dedicated to advancing the field of hepatopancreatobiliary surgery through innovative research and high-quality patient care. Located in Gansu Province, China, the institute specializes in the diagnosis, treatment, and surgical management of liver, pancreas, and biliary disorders, with a commitment to improving patient outcomes and enhancing surgical techniques. By conducting rigorous clinical trials, the institute aims to contribute to the global body of knowledge in surgical practices and therapies, fostering collaboration with healthcare professionals and institutions worldwide.

Locations

Lanzhou, Gansu, China

Patients applied

0 patients applied

Trial Officials

Wenbo Meng, M.D.

Principal Investigator

Hepatopancreatobiliary Surgery Institute of Gansu Province

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported